FindTrial
Sign In

The role of coagulation factors in the diagnoses and prognoses of pulmonary embolism among patients with lung cancer

The role of coagulation factors in the diagnoses and prognoses of pulmonary embolism among patients with lung cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100048872
Enrollment
Unknown
Registered
2021-07-19
Start date
2022-01-01
Completion date
Unknown
Last updated
2022-03-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pulmonary embolism, lung cancer

Interventions

high CF group:Nil
low CF group:Nil

Sponsors

Xinhua Hospital Affiliated to Shanghai Jiaotong University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. All patients are older than 18 years old; 2. All the patients had a definite histopathological diagnosis of primary lung cancer.

Exclusion criteria

Exclusion criteria: 1. Patients with other malignant tumors other than lung cancer; 2. Patients have a history of chronic pulmonary thromboembolism; 3. Patients have known thrombotic or coagulation disorders; 4. Patients received treatment affecting blood coagulation function within 1 week before enrollment; 5. Patients are pregnant or lactating woman; 6. Patients have expected survival time less than 3 months; 7. Patients refuse to sign the informed consent.

Design outcomes

Primary

MeasureTime frame
cumulative incidence of pulmonary embolism ival;cumulative survival rate;coagulation factor level;—

Countries

China

Contacts

Public ContactXiong Wei

Xinhua Hospital Affiliated to Shanghai Jiaotong University School of Medicine

xiongwei@xinhuamed.com.cn+86 15601890691

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026